Company News

Share this article:

The Department of Justice (DOJ), along with 16 states, has joined in two whistleblower suits filed in the District of Massachusetts against Wyeth. The suits allege that Wyeth knowingly failed to give the government the same discounts it provided to private purchasers of its drugs, as required by law under the Medicaid program. Wyeth allegedly “avoided paying hundreds of millions in rebates due to state Medicaid programs for its drugs Protonix Oral and Protonix IV,” two proton pump inhibitors, according to a DOJ release.

 

Takeda America, a subsidiary of Takeda Pharmaceutical Company, will acquire IDM Pharma. Millennium: The Takeda Oncology Company, will be responsible for global development on Mepact, IDM Pharma's bone cancer drug and primary asset.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.